Cargando…
Molecular Modeling and Experimental Evaluation of Non-Chiral Components of Bergamot Essential Oil with Inhibitory Activity against Human Monoamine Oxidases
Human monoamine oxidases (hMAOs) are well-established targets for the treatment of neurological disorders such as depression, Parkinson’s disease and Alzheimer’s disease. Despite the efforts carried out over the years, few selective and reversible MAO inhibitors are on the market. Thus, a continuous...
Autores principales: | Catalano, Raffaella, Procopio, Francesca, Chavarria, Daniel, Benfeito, Sofia, Alcaro, Stefano, Borges, Fernanda, Ortuso, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030833/ https://www.ncbi.nlm.nih.gov/pubmed/35458667 http://dx.doi.org/10.3390/molecules27082467 |
Ejemplares similares
-
Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles
por: Pinto, Miguel, et al.
Publicado: (2019) -
Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity
por: Guglielmi, Paolo, et al.
Publicado: (2019) -
Marine natural products with monoamine oxidase (MAO) inhibitory activity
por: Hong, Ahreum, et al.
Publicado: (2020) -
Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors
por: Maruca, Annalisa, et al.
Publicado: (2020) -
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats
por: Rombolà, Laura, et al.
Publicado: (2017)